Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Neoplasms by Site × osimertinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Stage IB-IIIA Non-small Cell Lung Carcinoma 1 Neoplasm Metastasis 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Carcinoma 1

Interventions

selpercatinib 2 ribociclib 1 repotrectinib 1 pralsetinib 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡